Skip to main content
SpringerLink
Log in

Surveillance Programmes and Antibiotic Resistance: Worldwide and Regional Monitoring of Antibiotic Resistance Trends

  • Chapter
  • First Online:
Antibiotic Resistance

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 211))

Abstract

Since the introduction of the penicillins many decades ago, multiple species of bacteria have responded to the use of antimicrobial agents in their ability to develop and transmit antimicrobial resistance. Increased consumption of antimicrobial agents, their misappropriate use among other factors have further catalysed this resistance phenomenon. As bacterial resistance is a global healthcare issue, appropriate monitoring through governmental, institutional and industry or pharmaceutical led surveillance programmes is essential. This chapter describes the resistance issue, factors affecting this issue and examples of such ongoing resistance surveillance programmes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 349.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 449.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 449.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Andrade S, Sader HS, Barth A (2008) Antimicrobial susceptibility of Gram-negative bacilli isolated in Brazilian hospitals participating in the SENTRY Program (2003–2008). Braz J Infect Dis 12:3–9

    Article  CAS  Google Scholar 

  • Ang JY, Ezike E, Asmar BL (2004) Antibacterial resistance. Indian J Pediatr 71:229–239

    Article  PubMed  Google Scholar 

  • Australian Government, Department of Health and Ageing (2009) Quarterly report. Comm Dis Intell 33:1–86

    Google Scholar 

  • Barbosa TM, Levy SB (2000) The impact of antibiotic use on resistance development and persistence. Drug Resist Updat 3:303–311

    Article  PubMed  Google Scholar 

  • Biedenbach DJ, Moet GJ, Jones RN (2004) Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002) Diagn Micro. Infect Dis 50:59–69

    CAS  Google Scholar 

  • Castanheira M, Deshpande LM, Bell JM et al (2010) Early dissemination of NDM-1 and OXA-181-producing Enterobacteriaceae in Indian Hospitals: Report from the SENTRY Antimicrobial Surveillance Program (2006–2007). Antimicrob Agents Chemother. doi: 10.1128/AAC.01497-10

    Google Scholar 

  • Centers for Disease Control and Prevention (2009a) Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2009

    Google Scholar 

  • Centers for Disease Control and Prevention (2009b) Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Neisseria meningiditis, 2009

    Google Scholar 

  • Centers for Disease Control and Prevention (2009c) Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2009

    Google Scholar 

  • Centers for Disease Control and Prevention (2009d) Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Methicillin-Resistant Staphylococcus aureus, 2008

    Google Scholar 

  • Centers for Disease Control and Prevention (2010) National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): Human Isolates Final Report, 2008. US Department of Health and Human Services, CDC, Atlanta, Georgia

    Google Scholar 

  • Cizman M (2003) The use and resistance to antibiotics in the community. Int J Antimicrob Agents 21:297–307

    Article  PubMed  CAS  Google Scholar 

  • DANMAP (2009) DANMAP 2009-Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark. ISSN 1600–2032

    Google Scholar 

  • Darabi A, Hocquet D, Dowzicky MJ (2010) Antimicrobial activity against Streptococcus pneumoniae and Haemophilus influenzae collected globally between 2004 and 2008 as part of the Tigecycline Evaluation and Surveillance Trial. Diagn Microbiol Infect Dis 67:78–86

    Article  PubMed  CAS  Google Scholar 

  • De Man P, Verhoeven BA, Verbrugh HA et al (2000) An antibiotic policy to prevent emergence of resistant bacilli. Lancet 355:973–978

    Article  PubMed  Google Scholar 

  • European Centre for Disease Prevention and Control (2010) Antimicrobial resistance surveillance in Europe 2009. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). ECDC, Stockholm

    Google Scholar 

  • Farrell DJ, Felmingham D, Shackcloth J et al (2008) Non-susceptibility trends and serotype distributions among Streptococcus pneumoniae from community-acquired respiratory tract infections and bacteremias in the UK and Ireland, 1999 to 2007. J Antimicrob Chemother 62(Suppl 2):ii87–ii95

    Article  PubMed  CAS  Google Scholar 

  • Felmingham D, Grunenburg RN, The Alexander Project Group (2000) The Alexander Project 1996–1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother 45:191–203

    Article  PubMed  CAS  Google Scholar 

  • Frimodt-Moller N, Hammerum AM, Hessler JHR et al (2007) Global development of resistance. Dan Med Bull 54:160–162

    PubMed  Google Scholar 

  • Gales AC, Sader HS, Ribeiro J et al (2009) Antimicrobial susceptibility of Gram-positive bacteria isolated in Brazilian hospitals participating in the SENTRY program (2005–2008). Braz J Infect Dis 13:90–98

    PubMed  CAS  Google Scholar 

  • Garcia-Rey C, Martin-Herrero JE, Baquero F (2006) Antibiotic consumption and generation of resistance in Streptococcus pneumoniae: the paradoxical impact of quinolones in a complex selective landscape. Clin Micro Infect 12(Suppl 3):55–66

    Article  CAS  Google Scholar 

  • Goossens H, Ferech M, Vander Stichele R et al (2005) Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365:579–587

    PubMed  Google Scholar 

  • Government of Canada (2010) Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) 2007. Public Health Agency of Canada

    Google Scholar 

  • Guillemot D, Carbon C, Balkau B et al (1998) Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumonaie. JAMA 279:365–370

    Article  PubMed  CAS  Google Scholar 

  • Hawser SP (2010) Activity of tigecycline and comparators against recent clinical isolates of Finegoldia magna from Europe. Eur J Clin Microbiol Infect Dis 29:1011–1013

    Article  PubMed  CAS  Google Scholar 

  • Hawser SP, Bouchillon SK, Hoban DJ et al (2009) Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007. Antimicrob Agents Chemother 53:3280–3284

    Article  PubMed  CAS  Google Scholar 

  • Hawser SP, Bouchillon SK, Hoban DJ et al (2010a) Epidemiologic trends, occurrence of extended-spectrum beta-lactamase production, and performance of ertapenem and comparators in patients with intra-abdominal infections: analysis of global trend data from 2002 to 2007 from the SMART study. Surg Infect 11:371–378

    Article  Google Scholar 

  • Hawser SP, Bouchillon SK, Hoban DJ et al (2010b) Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe – Results of the 2008 SMART Study. Antimicrob Agents Chemother 54:3043–3046

    Article  PubMed  CAS  Google Scholar 

  • Hawser SP, Hackel M, Person MB et al (2010c) In vitro activity of tigecycline against carbapenemase-producing Acinetobacter baumannii. Int J Antimicrob Agents 36:289–290

    Article  PubMed  CAS  Google Scholar 

  • Hawser SP, Hackel M, Hoban DJ (2010d) Antibiotic susceptibility profiles of European Bacteroides fragilis with reduced carbapenem susceptibility. J Antimicrob Chemother 65:803–804

    Article  PubMed  CAS  Google Scholar 

  • Hoban DJ, Bouchillon SK, Hawser SP et al (2010) Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007. Diag Microbiol Infect Dis 66:78–86

    Article  CAS  Google Scholar 

  • Hope R, Livermore DM, Brick G et al (2008) Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001–2006. J Antimicrob Chemother 62(Suppl 2):ii65–ii74

    Article  PubMed  CAS  Google Scholar 

  • Hsueh PR, Badal RE, Hawser SP et al (2010) Asia–Pacific SMART Group. Epidemiology and antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2008 results from SMART. Int J Antimicrob Agents 36:408–414

    Article  PubMed  CAS  Google Scholar 

  • Jones RN (1996) The emergent needs for basic research, education and surveillance of antimicrobial resistance. Problems facing the report from the American Society for Microbiology Task Force on Antibiotic Resistance. Diag Micro Infect Dis 25:153–161

    Article  CAS  Google Scholar 

  • Jones RN (1999) Beta-lactam resistance surveillance in the Asia-Western Pacific region. Diag Micro Infect Dis 35:333–338

    Article  CAS  Google Scholar 

  • Levy SB (1992) The antibiotic paradox. Plenum, New York

    Google Scholar 

  • Livermore DM, Hope R, Brick G et al (2008a) Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001–2006. J Antimicrob Chemother 62(Suppl 2):ii55–ii63

    Article  PubMed  CAS  Google Scholar 

  • Livermore DM, Hope R, Brick G et al (2008b) Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001–2006. J Antimicrob Chemother 62(Suppl 2):ii41–ii54

    Article  PubMed  CAS  Google Scholar 

  • Morrissey I, Maher K, Williams L et al (2008) Non-susceptibility trends amonh Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections in the UK and Ireland, 1999–2007. J Antimicrob Chemother 62(suppl 2):ii97–ii103

    Article  Google Scholar 

  • Myrianthefs PM, Kalafati M, Samara I et al (2004) Nosocomial pneumonia. Crit Care Nurs Q 27:241–257

    PubMed  Google Scholar 

  • Nagy E, Dowzicky MJ (2010) In vitro activity of tigecycline and comparators against a European compilation of anaerobes collected as part of the Tigecycline Evaluation and Surveillance Trial (TEST). Scand J Infect Dis 42:33–38

    Article  PubMed  CAS  Google Scholar 

  • Sader HS, Jones RN, Gales AC et al (2004) SENTRY antimicrobial surveillance program report: Latin America and Brazilian results for 1997 through 2001. Braz J Infect Dis 8:25–79

    Article  PubMed  CAS  Google Scholar 

  • Sahm DF, Marsilio MK, Piazza G (1999) Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database-USA. Clin Infect Dis 29:259–263

    Article  PubMed  CAS  Google Scholar 

  • Skalet AH, Cevallos V, Ayele B et al (2010) Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: A cluster-randomized clinical trial. PLoS Med 7:1–9

    Article  Google Scholar 

  • Standing Medical Advisory Committee Sub-Group on Antimicrobial Resistance (1998) The path of least resistance. Department of Health, London

    Google Scholar 

  • SWEDRES (2009) A report on Swedish Antimicrobial Utilisation and Resistance in Human Medicine. Swedish Strategic Programme against Antibiotic Resistance (STRAMA), Stockholm

    Google Scholar 

  • Tresoldi das Neves M, Pinto de Lorenzo ME, Almeida RAMB et al (2010) Antimicrobial use and incidence of multidrug-resistant Pseudomonas aeruginosa in a teaching hospital: an ecological approach. Rev Soc Brasil Med Trop 43:629–632

    Article  Google Scholar 

  • Vandepitte J, El-Nageh M, Tikhomirov E et al (1996) Guidelines for antimicrobial resistance surveillance; WHO Regional Publications Eastern Mediterranean Series 15. WHO Regional Office for the Eastern Mediterranean, Alexandria

    Google Scholar 

  • Wang YF, Dowzicky MJ (2010) In vitro activity of tigecycline and comparators on Acinetobacter spp. isolates collected from patients with bacteremia and MIC change during the Tigecycline Evaluation and Surveillance Trial, 2004 to 2008. Diagn Microbiol Infect Dis 68:73–79

    Article  PubMed  CAS  Google Scholar 

  • Zhang R, Eggleston K, Rotimi V et al (2006) Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States. Global Health 2:6

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. IHMA Europe Sàrl, 9A Route de la Corniche, 1066, Epalinges, Switzerland

    Stephen Hawser

Authors
  1. Stephen Hawser
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephen Hawser .

Editor information

Editors and Affiliations

  1. , Div of Cellular and Molecular Medicine, St. George's, University of London, Cranmer Terrace, London, SW17 0RE, United Kingdom

    Anthony R.M. Coates

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hawser, S. (2012). Surveillance Programmes and Antibiotic Resistance: Worldwide and Regional Monitoring of Antibiotic Resistance Trends. In: Coates, A. (eds) Antibiotic Resistance. Handbook of Experimental Pharmacology, vol 211. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-28951-4_3

Download citation

Publish with us

Policies and ethics

Search

Navigation